>아시아 태평양 폐암 수술 시장, 제품 유형별( 수술 도구 , 모니터링 및 시각화 시스템, 수술 내시경 장비, 로봇 보조 흉부 수술 시스템 및 기타), 수술 절차(흉곽절개술 및 최소 침습 수술 ), 환자 유형(남성 및 여성), 최종 사용자(병원, 외래 수술 센터 , 학술 및 연구 실험실, 전문 암 치료 센터 및 기타), 유통 채널(직접 입찰, 소매 판매, 온라인 판매 및 기타) - 업계 동향 및 2029년까지의 예측.
아시아 태평양 폐암 수술 시장 분석 및 통찰력
쐐기 수술은 소량의 좋은 조직과 함께 폐암을 제거하는 데 사용되는 시술입니다. 분절 절제는 폐의 더 큰 부분을 제거하는 것을 말합니다. 폐엽 절제술은 폐의 다섯 엽 중 하나를 제거하는 시술입니다. 폐절제술은 폐 전체를 외과적으로 제거하는 것입니다.
아시아 태평양 폐암 수술 시장은 2022년부터 2029년까지의 예측 기간 동안 상당한 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 6.0%의 CAGR로 성장하고 있으며 2029년까지 1,368.70백만 달러에 도달할 것으로 예상한다고 분석합니다.
보고서 메트릭 |
세부 |
예측 기간 |
2022년부터 2029년까지 |
기준 연도 |
2021 |
역사적 연도 |
2020 (사용자 정의 가능 2019-2014) |
양적 단위 |
수익 (단위: USD 백만) |
다루는 세그먼트 |
제품 유형별(수술 기구, 모니터링 및 시각화 시스템, 내시경 수술 장비, 로봇 보조 흉부 수술 시스템 및 기타), 수술 절차(흉곽 절개술 및 최소 침습 수술), 환자 유형(남성 및 여성), 최종 사용자(병원, 외래 수술 센터, 학술 및 연구 실험실, 전문 암 치료 센터 및 기타), 유통 채널(직접 입찰, 소매 판매, 온라인 판매 및 기타) |
적용 국가 |
중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 아시아 태평양의 나머지 지역 |
시장 참여자 포함 |
이 시장에 진출한 주요 기업으로는 Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology (Beijing) Co, Ltd., Intuitive Surgical, FusionKraft, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH 등이 있습니다. |
시장 정의
폐암의 종류, 위치, 단계 및 기타 의학적 문제에 따라 특정 사람들은 폐암 수술의 후보가 될 수 있습니다. 이러한 종류의 수술은 폐암을 치료하는 데 사용됩니다. 여기에는 종양, 그 주변의 일부 폐 조직, 그리고 종종 일부 림프절도 제거하는 것이 포함됩니다. 폐암이 제한적이고 전이되지 않을 것으로 예상되면 종양을 제거하는 수술이 가장 좋은 옵션으로 여겨집니다. 여기에는 초기 단계의 카르시노이드 종양과 비소세포 폐암이 포함됩니다.
폐암 수술 시장 동향
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
-
Increased Prevalence Of Lung Cancer Diseases
Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to Asia-Pacific health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.
-
Technological Advancement In The Field Of Healthcare
Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.
In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market
-
Increased Awareness Regarding The Benefits
The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.
The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the Asia-Pacific lung cancer surgery market.
Opportunities
-
Rise of Minimally Invasive Techniques in Lung Cancer Surgery
Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.
Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the Asia-Pacific lung cancer surgery market.
Restraints/Challenges
However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market
This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lung Cancer Surgery Market
All industries, including healthcare, medical device services, automotive, pharmaceutical and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lung cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lung cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion and population lockdown, all of which slow down referrals and patient flow.
The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lung cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number and vaccination against it is increasing across the Asia-Pacific.
Recent Development
- In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.
Asia-Pacific Lung Cancer Surgery Market Scope
Asia-Pacific lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user, and distribution channel. The growth amongst these segments will help you analyses meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
- Surgical Instruments
- Monitoring & Visualizing System
- Endosurgical Equipment
- Robotic-Assisted Thoracic Surgery Systems
- Others
On the basis of product type, the Asia-Pacific lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.
Surgical Procedure
- Thoracotomy
- Minimally Invasive Surgery
On the basis of surgical procedure, the Asia-Pacific lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.
Patient Type
- Male
- Female
On the basis of patient type, the Asia-Pacific lung cancer surgery market is segmented into male and female.
End User
- Hospitals
- Ambulatory & Surgical Centers
- Academic & Research Institutes
- 전문 암 치료 센터
- 기타
아시아 태평양 폐암 수술 시장은 최종 사용자를 기준으로 병원, 외래 및 수술 센터, 학술 및 연구 기관, 전문 암 치료 센터 및 기타로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
- 온라인 판매
- 기타
아시아 태평양 폐암 수술 시장은 유통 채널을 기준으로 직접 입찰, 소매 판매, 온라인 판매 및 기타로 구분됩니다.
폐암 수술 시장 지역 분석/통찰력
폐암 수술 시장을 분석하고, 위에 언급된 대로 국가, 제품 유형, 수술 과정, 환자 유형, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
아시아 태평양 폐암 수술 시장은 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀 및 기타 아시아 태평양 국가로 구성됩니다.
중국은 시장 점유율과 시장 수익 측면에서 아시아 태평양 폐암 수술 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다. 이는 국가에서 종양 수술 과정의 검증 및 타당성에 대한 필요성이 증가하고 연구 개발이 빠르게 진행되고 있기 때문입니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 폐암 수술 시장 점유율 분석
폐암 수술 시장 경쟁 구도는 경쟁자들의 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 폐암 수술 시장에 대한 회사의 초점과만 관련이 있습니다.
폐암 수술 시장의 주요 기업으로는 AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology(Beijing) Co., Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation 등이 있습니다.
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 아시아 태평양 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 EPIDEMIOLOGY
5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY
5.2 TREATMENT RATE BY GENDER
5.3 MORTALITY BY GENDER
6 REGULATIONS OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES
7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS
7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING
7.2 RESTRAINTS
7.2.1 HIGH COST OF LUNG CANCER SURGERY
7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS
7.2.3 STRINGENT REGULATORY FRAMEWORKS
7.3 OPPORTUNITIES
7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY
7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY
7.4 CHALLENGES
7.4.1 DEARTH OF SKILLED ONCOLOGISTS
7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES
8 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SURGICAL INSTRUMENTS
8.2.1 HAND INSTRUMENTS
8.2.1.1 STAPLER
8.2.1.2 FORCEPS
8.2.1.3 ELECTRIC HOOK
8.2.1.4 RETRACTORS
8.2.1.5 CLAMPS
8.2.1.6 SCISSORS
8.2.1.7 ELEVATORS
8.2.1.8 HEMOCLIP APPLIERS
8.2.1.9 ULTRASOUND SCALPEL
8.2.1.10 RIB SHEARS
8.2.1.11 CUTTERS
8.2.1.12 NEEDLE HOLDER
8.2.1.13 TROCAR
8.2.1.14 OTHERS
8.2.2 POWERED SURGICAL EQUIPMENT
8.2.2.1 ADVANCED ENERGY INSTRUMENTS
8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS
8.2.2.1.2 OTHERS
8.2.2.2 BASIC ENERGY INSTRUMENTS
8.2.2.2.1 BIPOLAR INSTRUMENTS
8.2.2.2.2 MONOPOLAR INSTRUMENTS
8.3 MONITORING & VISUALISING SYSTEM
8.3.1 CAMERAS & VIDEO SUPPORT
8.3.2 BRONCHOSCOPES
8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
8.3.4 THORACOSCOPES
8.3.5 MEDIASTINOSCOPES
8.3.6 OTHERS
8.4 ENDOSURGICAL EQUIPMENTS
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS
8.6 OTHERS
9 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
9.1 OVERVIEW
9.2 THORACOTOMY
9.2.1 LOBECTOMY
9.2.1.1 SURGICAL INSTRUMENTS
9.2.1.2 MONITORING & VISUALISING SYSTEMS
9.2.1.3 ENDOSURGICAL EQUIPMENT
9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.1.5 OTHERS
9.2.2 SLEEVE RESECTION
9.2.2.1 SURGICAL INSTRUMENTS
9.2.2.2 MONITORING & VISUALISING SYSTEMS
9.2.2.3 ENDOSURGICAL EQUIPMENT
9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.2.5 OTHERS
9.2.3 SEGMENTECTOMY
9.2.3.1 SURGICAL INSTRUMENTS
9.2.3.2 MONITORING & VISUALISING SYSTEMS
9.2.3.3 ENDOSURGICAL EQUIPMENT
9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.3.5 OTHERS
9.2.4 PNEUMONECTOMY
9.2.4.1 SURGICAL INSTRUMENTS
9.2.4.2 MONITORING & VISUALISING SYSTEMS
9.2.4.3 ENDOSURGICAL EQUIPMENT
9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.4.5 OTHERS
9.2.5 OTHERS
9.3 MINIMALLY INVASIVE SURGERIES
9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)
9.3.1.1 SURGICAL INSTRUMENTS
9.3.1.2 MONITORING & VISUALISING SYSTEMS
9.3.1.3 ENDOSURGICAL EQUIPMENT
9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.1.5 OTHERS
9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)
9.3.2.1 SURGICAL INSTRUMENTS
9.3.2.2 MONITORING & VISUALISING SYSTEMS
9.3.2.3 ENDOSURGICAL EQUIPMENT
9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.2.5 OTHERS
10 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 MALE
10.2.1 GERIATRIC
10.2.1.1 THORACOTOMY
10.2.1.2 MINIMALLY INVASIVE SURGERIES
10.2.2 ADULTS
10.2.2.1 THORACOTOMY
10.2.2.2 MINIMALLY INVASIVE SURGERIES
10.2.3 PEDIATRIC
10.2.3.1 THORACOTOMY
10.2.3.2 MINIMALLY INVASIVE SURGERIES
10.3 FEMALE
10.3.1 GERIATRIC
10.3.1.1 THORACOTOMY
10.3.1.2 MINIMALLY INVASIVE SURGERIES
10.3.2 ADULTS
10.3.2.1 THORACOTOMY
10.3.2.2 MINIMALLY INVASIVE SURGERIES
10.3.3 PEDIATRIC
10.3.3.1 THORACOTOMY
10.3.3.2 MINIMALLY INVASIVE SURGERIES
11 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC HOSPITALS
12.2.2 PRIVATE HOSPITALS
12.3 AMBULATORY SURGICAL CENTERS
12.4 SPECIALTY CANCER CARE CENTERS
12.5 ACADEMIC AND RESEARCH LABORATORIES
12.6 OTHERS
13 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 MALAYSIA
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 JOHNSON & JOHNSON SERVICES, INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ACCURAY INCORPORATED
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 INTUITIVE SURGICAL
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FUJIFILM HOLDINGS CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AMBU A/S.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ANGIODYNAMICS
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ACKERMANN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCTPORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 FUSIONKRAFT
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 GERMED USA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 KLS MARTIN GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 KARL STORZ SE & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEDTRONICS (2021)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 OLYMPUS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCTPORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 RICHARD WOLF GMBH.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 SURGICAL HOLDINGS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SONTEC INSTRUMENTS, INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SCANLAN INTERNATIONAL
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TELEFLEX INCORPORATED
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCTPORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TROKAMED GMBH.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 WEXLER SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020
TABLE 2 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 7 ASIA PACIFIC POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 11 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 14 ASIA PACIFIC ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 ASIA PACIFIC HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 50 ASIA PACIFIC OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 ASIA-PACIFIC LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 ASIA PACIFIC LUNG CANCER SURGERYMARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 ASIA PACIFIC LUNG CANCER SURGERYMARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH
FIGURE 6 ASIA PACIFIC LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH
FIGURE 7 ASIA PACIFIC LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID
FIGURE 11 ASIA PACIFIC LUNG CANCER SURGERY MARKET SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE ASIA PACIFIC LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC LUNG CANCER SURGERY MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC LUNG CANCER SURGERY MARKET
FIGURE 15 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021
FIGURE 20 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021
FIGURE 24 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 28 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, 2021
FIGURE 32 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 36 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 37 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 40 ASIA PACIFIC LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.